{"id":21794,"date":"2022-05-03T14:02:23","date_gmt":"2022-05-03T14:02:23","guid":{"rendered":"https:\/\/nclnet.org\/?page_id=21794"},"modified":"2022-05-03T14:02:23","modified_gmt":"2022-05-03T14:02:23","slug":"health-advisory-council-newsletter-spring-2022-health-policy-updates","status":"publish","type":"page","link":"https:\/\/nclnet.org\/health-advisory-council-newsletter-spring-2022-health-policy-updates\/","title":{"rendered":"Health Advisory Council Newsletter | Spring 2022 | Health Policy Updates"},"content":{"rendered":"\n<style type=\"text\/css\" id=\"style-css-av-k941ur2y-073151a68b06a10c493ad5ad5242604d\">\n.avia-section.av-k941ur2y-073151a68b06a10c493ad5ad5242604d{\nbackground-repeat:no-repeat;\nbackground-image:url(https:\/\/nclnet.org\/wp-content\/uploads\/2020\/11\/77_dsp7890_lr.jpg);\nbackground-position:top center;\nbackground-attachment:scroll;\n}\n.avia-section.av-k941ur2y-073151a68b06a10c493ad5ad5242604d .av-section-color-overlay{\nopacity:0.5;\nbackground-color:#000000;\n}\n<\/style>\n<div id='av_section_1'  class='avia-section av-k941ur2y-073151a68b06a10c493ad5ad5242604d main_color avia-section-default avia-no-border-styling  avia-builder-el-0  el_before_av_hr  avia-builder-el-first  avia-full-stretch avia-bg-style-scroll av-section-color-overlay-active  av-minimum-height av-minimum-height-50  container_wrap sidebar_right'  data-section-bg-repeat='stretch' data-av_minimum_height_pc='50'><div class='av-section-color-overlay-wrap'><div class=\"av-section-color-overlay\"><\/div><div class='container av-section-cont-open' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-21794'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" id=\"style-css-av-knzbct7q-7172ea84ea09ee37ee3e584b71e2b672\">\n#top .av-special-heading.av-knzbct7q-7172ea84ea09ee37ee3e584b71e2b672{\npadding-bottom:10px;\ncolor:#ffffff;\nfont-size:30px;\n}\n.av-special-heading.av-knzbct7q-7172ea84ea09ee37ee3e584b71e2b672 .special-heading-inner-border{\nborder-color:#ffffff;\n}\n<\/style>\n<div  class='av-special-heading av-knzbct7q-7172ea84ea09ee37ee3e584b71e2b672 av-special-heading-h3 custom-color-heading blockquote modern-quote  avia-builder-el-1  avia-builder-el-no-sibling  banner-heading av-inherit-size '><h3 class='av-special-heading-tag '  itemprop=\"headline\"  >Health Advisory Council Newsletter | Spring 2022<\/h3><div class='special-heading-border'><div class='special-heading-inner-border'><\/div><\/div><\/div>\n<\/div><\/div><\/main><!-- close content main element --><\/div><\/div><\/div><div id='after_section_1'  class='main_color av_default_container_wrap container_wrap sidebar_right'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-21794'><div class='entry-content-wrapper clearfix'><div  class='hr av-112pyqs-bcdac3a3f6691f0e01891747ee1e7453 hr-default  avia-builder-el-2  el_after_av_section  el_before_av_heading  avia-builder-el-first  '><span class='hr-inner '><span class=\"hr-inner-style\"><\/span><\/span><\/div><\/p>\n\n<style type=\"text\/css\" id=\"style-css-av-vhd5yc-981b32843e5acea8c99f777c4544ef9d\">\n#top .av-special-heading.av-vhd5yc-981b32843e5acea8c99f777c4544ef9d{\npadding-bottom:10px;\n}\n<\/style>\n<div  class='av-special-heading av-vhd5yc-981b32843e5acea8c99f777c4544ef9d av-special-heading-h3  avia-builder-el-3  el_after_av_hr  el_before_av_hr  '><h3 class='av-special-heading-tag '  itemprop=\"headline\"  >NCL Health Policy at Work<\/h3><div class='special-heading-border'><div class='special-heading-inner-border'><\/div><\/div><\/div>\n<div  class='hr av-n77a78-422db94a33b852796e03519b41330311 hr-default  avia-builder-el-4  el_after_av_heading  el_before_av_one_full  '><span class='hr-inner '><span class=\"hr-inner-style\"><\/span><\/span><\/div>\n\n<style type=\"text\/css\" id=\"style-css-av-fwkdh-212ea64b2fae7ca329b32373e76e8d17\">\n#top .flex_column.av-fwkdh-212ea64b2fae7ca329b32373e76e8d17{\nborder-radius:0px;\n-webkit-border-radius:0px;\n-moz-border-radius:0px;\npadding:0px;\n}\n<\/style>\n<div class='flex_column av-fwkdh-212ea64b2fae7ca329b32373e76e8d17 av_one_full  avia-builder-el-5  el_after_av_hr  avia-builder-el-last  first flex_column_div av-zero-column-padding '   ><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock  '   itemprop=\"text\" ><p><b><span data-contrast=\"none\">Access to Safe Medical Devices<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">NCL is proud to advocate for consumer access to safe and effective FDA approved drugs and medical devices. Since December of last year, NCL has been engaging with the FDA on the need for increased sound safety levels when establishing new\u202fOver the Counter (OTC) hearing aids<\/span><span data-contrast=\"auto\">\u200b. NCL recently garnered <\/span><a href=\"https:\/\/nclnet.org\/ncl-leads-effort-otc-hearing-aids\/\"><span data-contrast=\"none\">co-signers from 29 aligned non-profit stakeholders<\/span><\/a><span data-contrast=\"auto\"> for a letter to FDA Commissioner Robert Califf, calling for stronger measures to better protect consumers affected by this new category of medical devices.<\/span><br \/>\n<span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"none\">Prescription Drug Pricing<\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">On March 29, NCL led a discussion with key experts on the role of Pharmacy Benefit Managers (PBMs) in driving up prescription drug prices. You can watch the recording and learn more here: <\/span><a href=\"https:\/\/nclnet.org\/pbms\"><span data-contrast=\"none\">https:\/\/nclnet.org\/pbms<\/span><\/a><span data-contrast=\"auto\">. The Federal Trade Commission (FTC) is seeking public comment on how PBM practices impact consumer access. NCL is leading consumer outreach efforts to elicit public comment via a grassroots advocacy letter writing campaign. The comment period was extended through May 25. Please share widely and encourage consumers to share their story with the FTC <\/span><a href=\"https:\/\/p2a.co\/m04lXYX\"><span data-contrast=\"none\">here<\/span><\/a><span data-contrast=\"auto\">.<\/span><br \/>\n<span data-contrast=\"auto\">\u202f<\/span><\/p>\n<p><span data-contrast=\"auto\">On April 26, NCL hosted a briefing titled \u201cMeasuring the 340B Program\u2019s Impact on Charitable Care and Operating Profits for Covered Entities\u201d. The 340B program requires that drug manufacturers provide deep discounts for their products to charity and nonprofit hospitals, with the 340B program conceived to defray the drug costs for patients. NCL is calling on Congress to hold hearings into abuses of the 340B program, in order to correct them with legislation or further federal oversight. This would ensure that patients are getting the benefits that Congress initially intended with this program. Learn more and view the recording here: <\/span><a href=\"https:\/\/nclnet.org\/340b_briefing\/\"><span data-contrast=\"none\">https:\/\/nclnet.org\/340b_briefing\/<\/span><\/a><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"none\">Vaccine Advocacy<\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Adult immunization is an important consumer issue, especially during the COVID-19 pandemic. NCL has been working\u202fto increase awareness of the need\u202ffor adult vaccine uptake. On February 23, NCL submitted comments to the CDC\u2019s Advisory Committee on Immunization Practices (ACIP). In these comments, NCL applauded the FDA for <\/span><a href=\"https:\/\/www.cdc.gov\/ticks\/tbe_vaccine\/index.html\"><span data-contrast=\"none\">approving a new vaccine for Tick Borne Encephalitis<\/span><\/a><span data-contrast=\"auto\"> (TBE), which currently has not specific treatment. NCL also called for the CDC to follow with a strong recommendation to ensure equitable access.\u00a0 In its comments, NCL also stresses the importance of protecting older adults from influenza and is encouraged that ACIP is considering recommendations for preferential use of enhanced seasonal influenza vaccines over standard vaccines in adults aged 65 and older. Lastly, NCL called on the CDC to provide clearer recommendations to help increase uptake of the pneumococcal vaccine, and pledges to continue encouraging consumers to ask their healthcare provider about protection against pneumococcal disease, and other vaccine preventable diseases.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"none\">Script Your Future\u00a0<\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">This year marks the 11<\/span><span data-contrast=\"auto\">th<\/span><span data-contrast=\"auto\">\u202fyear for NCL\u2019s\u202f<\/span><i><span data-contrast=\"auto\">Script Your Future<\/span><\/i><span data-contrast=\"auto\">\u202fTeam Challenge, and we are pleased to report several innovations to the program. <\/span><a href=\"https:\/\/nclnet.org\/2022_team_challenge_launch\/\"><span data-contrast=\"none\">This year<\/span><\/a><span data-contrast=\"auto\">, participants from 24 schools focused their outreach on three health issues: medication adherence, vaccine confidence, and safe drug disposal. The Team Challenge ran from January 17<\/span><span data-contrast=\"auto\">th<\/span><span data-contrast=\"auto\"> to March 28<\/span><span data-contrast=\"auto\">th<\/span><span data-contrast=\"auto\">, and schools submitted their summary reports to NCL. We are currently in the process of scoring reports, so check back at <\/span><a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fscriptyourfuture.org%2F&amp;data=05%7C01%7CJeanettec%40nclnet.org%7Cffb3afef360040eac62908da26daf062%7C4e1d2f3fec00459892401b9071ab6582%7C1%7C0%7C637865019027840730%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=X5bXqYQgRrBSyO4Gq6xQe8Q7GiW%2FD4ejjcHWrSSCHe0%3D&amp;reserved=0\"><span data-contrast=\"none\">ScriptYourFuture.org<\/span><\/a> <span data-contrast=\"auto\">in a few weeks for announcement of the 2022 Team Challenge winners!\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">NCL is also proud to be launching the <\/span><a href=\"https:\/\/scriptyourfuture.org\/alumni\/about-alumni\/\"><span data-contrast=\"none\">Script Your Future Alumni Network<\/span><\/a><span data-contrast=\"none\">. Thousands of pharmacists have participated in the SYF Team Challenge over the last ten years. We aim to build the founding members of the alumni network from this year\u2019s Team Challenge participants.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"none\">Treatment Adherence Summit in NOLA: Join Us!<\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Join NCL and the Infusion Access Foundation (IAF) for a Treatment Adherence Summit on\u202fSunday, June 19 in New Orleans, <\/span><span data-contrast=\"auto\">LA. NCL is presenting a panel with the IAF to discuss the role of non-adherence in driving disparate health outcomes for patients managing chronic conditions and infusion treatment. The discussion will focus on sharing strategies and public health interventions to improve medication and treatment adherence in diverse communities.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Let us know if you have community partners based in New Orleans who would be interested in attending the summit. We would be happy to send them a personal invitation.<\/span><span data-contrast=\"none\">\u202f<\/span><a href=\"https:\/\/pages.actmkt.com\/(S(gyi5qv3ejzmhg11g3sptsxuc))\/l\/IAFSummit2022\"><span data-contrast=\"none\">Click here<\/span><\/a><span data-contrast=\"none\"> for more information and to register!\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<div class=\"_3BpnlUwgtfNUWLoQytJYRy\">\n<div class=\"\">\n<div class=\"wide-content-host\">\n<div class=\"_3BL964mseejjC_nzEeda9o NN4ve7-zXI11J6Er51ULd\" tabindex=\"-1\" aria-label=\"Email message\">\n<div class=\"_2Qk4AbDuWwkuLB005ds2jm QMubUjbS-BOly_BTHEZj7 allowTextSelection\">\n<div>\n<div>\n<div lang=\"en-US\">\n<div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":9,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false},"acf":[],"_links":{"self":[{"href":"https:\/\/nclnet.org\/wp-json\/wp\/v2\/pages\/21794"}],"collection":[{"href":"https:\/\/nclnet.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nclnet.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nclnet.org\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nclnet.org\/wp-json\/wp\/v2\/comments?post=21794"}],"version-history":[{"count":2,"href":"https:\/\/nclnet.org\/wp-json\/wp\/v2\/pages\/21794\/revisions"}],"predecessor-version":[{"id":21803,"href":"https:\/\/nclnet.org\/wp-json\/wp\/v2\/pages\/21794\/revisions\/21803"}],"wp:attachment":[{"href":"https:\/\/nclnet.org\/wp-json\/wp\/v2\/media?parent=21794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}